Skye Bioscience Inc.
SKYE | NASDAQ
$1.75
-$0.03 (-1.69%)
Sep 22, 2026, 12:53 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.53 | -3.88 | -0.51 | -0.46 | -2.60 | -1.41 |
PEG Ratio | -0.01 | 0.04 | 0.01 | -0.01 | 0.09 | 0 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.49 | 1.52 | -8.94 | -2.95 | 3.61 | 20.47 |
P/FCF Ratio | -0.69 | -3.85 | -1.36 | -0.70 | -3.22 | -1.52 |
P/OCF Ratio | -0.69 | -4.09 | -1.37 | -0.70 | -3.27 | -1.52 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.01 | -2.16 | -0.66 | 0.36 | 3.32 |
Quick Ratio | 3.30 | 16.32 | 0.84 | 0.74 | 2.46 | 3.38 |
Current Ratio | 3.30 | 16.32 | 0.84 | 0.74 | 2.46 | 3.38 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -31.20 | -38.33 | -27.59 | -10.22 | -8.90 |
Return on Equity | -279.29% | -38.98% | 1.77K% | 647.65% | -145.33% | -1.46K% |
Return on Assets | -197.52% | -36.51% | -315.27% | -213.82% | -86.47% | -245.57% |
Return on Invested Capital | -286.55% | -44.01% | -1.4K% | 1.79K% | -98.09% | -322.75% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove SKYE